High SHBG With High Total Testosterone in Women: What That Pattern Means
High sex hormone-binding globulin (SHBG) alongside high total testosterone in a woman usually means the extra testosterone is bound and not biologically available. SHBG is the liver-made carrier protein that holds most circulating testosterone with high affinity. When SHBG rises, total testosterone rises with it because the bound pool grows, while the free and bioavailable fractions can stay flat or normal. So the first move is not to interpret the total at all. Compute free and bioavailable testosterone, and treat the elevated SHBG as the finding that needs explaining.
That said, the pattern has a second reading. If free testosterone is also high despite the elevated binding capacity, androgen production is genuinely increased and the source matters. That question belongs with an endocrinologist, because the workup involves adrenal and ovarian imaging decisions we cannot make from a data file.
Get the measurement right before interpreting anything
Female testosterone concentrations sit near the bottom of the range that immunoassays handle well. Direct immunoassays for total testosterone are known to read imprecisely below roughly 100 ng/dL, and direct free testosterone immunoassays (“analog” assays) are worse. Ask for total testosterone by liquid chromatography–tandem mass spectrometry (LC-MS/MS) and get SHBG and albumin from the same draw. Then calculate the free fraction rather than measuring it directly.
Timing and exposures change the result more than most people expect. Serum biomarker distributions in women shift with menstrual phase and with hormonal contraceptive use, which is one of the strongest single determinants of measured SHBG.1 If you are cycling, draw in the early follicular phase and in the morning. Record whether you are on an oral estrogen. A single SHBG value in isolation is close to uninterpretable. Two or three draws over a few months tell you whether you have a high setpoint or a transient shift.
Units cause avoidable confusion. SHBG is reported in nmol/L. Total testosterone is reported in ng/dL in the United States and nmol/L elsewhere. Multiply ng/dL by 0.0347 to get nmol/L. Albumin in g/dL times 10 gives g/L.
Compute free and bioavailable testosterone from your own panel
The standard approach is the Vermeulen calculation, a closed-form solution to the mass-action equilibrium between testosterone, SHBG, and albumin. It needs three numbers you already have. Here it is explicitly, so you can check any calculator you find online.
def vermeulen(total_T_nmol_L, shbg_nmol_L, albumin_g_L=43.0):
# association constants, L/mol
K_shbg = 1.0e9
K_alb = 3.6e4
T = total_T_nmol_L * 1e-9
S = shbg_nmol_L * 1e-9
A = (albumin_g_L / 66500.0) # 66.5 kDa -> mol/L
N = K_alb * A + 1.0
a = N * K_shbg
b = N + K_shbg * (S - T)
c = -T
freeT = (-b + (b*b - 4*a*c) ** 0.5) / (2*a)
bioT = freeT * N
return freeT * 1e9, bioT * 1e9 # nmol/L
Work an example. Total testosterone of 72 ng/dL (2.50 nmol/L) with SHBG of 145 nmol/L and albumin of 43 g/L returns a free testosterone around 0.015 nmol/L, roughly 4.3 pg/mL. That is an unremarkable free level sitting under a total at or above the top of most female reference intervals. Now hold the total fixed and drop SHBG to 35 nmol/L. Free testosterone roughly triples. The total told you almost nothing on its own.
Two caveats on the math. The Vermeulen model assumes one binding site per SHBG molecule and standard affinity constants, and it is less accurate at extreme SHBG values, which is exactly where you are if SHBG is above 150 nmol/L. Equilibrium dialysis is the reference method if the calculated value drives a clinical decision. Free androgen index (total T divided by SHBG, both in nmol/L) is a cruder ratio and we would not rely on it when albumin is available.
What pushes SHBG up
SHBG transcription in hepatocytes responds to hormonal and metabolic input, so a high value is a readout on liver state rather than a gonadal one. A few causes recur, in rough order of how often they explain a surprising result. They are oral estrogen exposure, thyroid hormone excess and liver disease with altered hepatic synthesis, followed by sustained energy deficit and genetic setpoint. Reviews of SHBG as a diagnostic marker place hyperthyroidism and hepatic pathology among the classic drivers of markedly elevated levels.2
Oral estrogen matters because of first-pass hepatic exposure. Combined oral contraceptives and oral estradiol raise SHBG substantially, transdermal routes much less. Thyroid hormone is a direct transcriptional stimulus, so an unexplained SHBG of 150 to 250 nmol/L justifies checking TSH and free T4 with a clinician. Very low energy availability, whether from anorexia nervosa or from high training volume with insufficient intake, also raises SHBG. Prolonged physically demanding deployments shift SHBG and androgen measures in ways that track load and energy balance.3
Note the direction of the metabolic association, because it runs opposite to most people’s intuition. Low SHBG, not high, is the insulin-resistant phenotype. SHBG sits in biomarker panels for obesity risk and is inversely related to adiposity.4 In dysglycemic women at high cardiovascular risk, SHBG and testosterone relate to incident outcomes in a pattern where low SHBG marks the adverse metabolic state.5 High SHBG is likewise the opposite of the polycystic ovary syndrome signature, where SHBG is characteristically low and contributes to elevated free androgens.6 If your SHBG is high, PCOS becomes a less likely explanation for any androgenic symptoms.
What your genome says about your SHBG setpoint
Circulating SHBG and testosterone are substantially heritable in women, with family-based estimates in the Framingham cohort placing SHBG heritability in the same range as many common quantitative traits.7 That means a chronically high SHBG with a normal free testosterone and normal thyroid function may simply be your baseline.
If you have a whole-genome VCF, two variants at the SHBG locus on chromosome 17 are worth looking up. Query them directly rather than trusting a consumer report.
bcftools query -f '%CHROM\t%POS\t%ID\t%REF\t%ALT[\t%GT]\n' \
-r chr17:7630000-7645000 sample.g.vcf.gz | grep -E 'rs6259|rs1799941'
The rs6259 missense variant (D327N) alters the protein and associates with higher measured SHBG, partly through slower clearance. The promoter variant rs1799941 also associates with higher SHBG. Effect sizes are modest and additive, on the order of a few nmol/L per allele rather than a doubling. They help explain a stable high value. They do not rule out an acquired cause. Check your VCF depth and genotype quality at those positions before believing the call.
Reading a high SHBG longitudinally
One SHBG value answers little. A time series answers a lot. Draw SHBG, total testosterone by LC-MS/MS and albumin together with TSH, free T4 and liver enzymes. Take the panel at the same time of day and cycle phase, three or four times across a year. Overlay body composition and any change in oral estrogen exposure. A setpoint that holds steady across conditions is probably genetic. A value that tracks thyroid function or an estrogen start is explained.
If you have proteomic data, SHBG appears on the common affinity panels, though relative units there are not interchangeable with a clinical nmol/L immunoassay. Use the proteomics for trajectory and the clinical assay for absolute level. SHBG in older women also travels with inflammatory markers, so a rising SHBG alongside rising inflammatory proteins is a different signal from a rising SHBG in isolation.8
Questions people also ask
Can high SHBG cause weight gain? The association runs the other way. Low SHBG tracks with adiposity and insulin resistance in large cohorts, and SHBG appears in obesity risk biomarker panels as an inverse marker.4 High SHBG is not a recognized cause of weight gain.
What does high SHBG feel like? By itself, nothing specific. Any symptoms attributed to it usually come from the reduced free androgen or free estrogen that accompanies it, or from the underlying cause such as thyroid excess or energy deficit. That is why the useful reading is the calculated free fraction plus a cause. The SHBG number alone is not enough.
What causes extremely high SHBG? Values well above 200 nmol/L most often reflect oral estrogen, hyperthyroidism, advanced liver disease or severe energy restriction.2 Pregnancy raises SHBG severalfold and should be excluded before any other interpretation.
Is it better for SHBG to be high or low? Metabolically, higher SHBG is the more favorable end of the distribution, since low SHBG marks insulin resistance and dysglycemic risk in women.5 Very high SHBG is a flag to look for a cause rather than a problem in itself.
How do you treat high SHBG levels? SHBG is not a treatment target. The cause is what gets addressed, and identifying it requires a clinician who can order and interpret thyroid and hepatic testing in context.
Footnotes
-
Jordan M. Ramsey, Jason D. Cooper, Brenda W. J. H. Penninx, et al. Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests. Scientific Reports, 2016. https://doi.org/10.1038/srep26947 ↩
-
Weronika Szybiak-Skora, Wojciech Cyna, Katarzyna Lacka. New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach. Biomedicines, 2025. https://doi.org/10.3390/biomedicines13051207 ↩ ↩2
-
Kai Pihlainen, Matti Santtila, Tommi Vasankari, et al. Evaluation of occupational physical load during 6-month international crisis management operation. International Journal of Occupational Medicine and Environmental Health, 2017. https://doi.org/10.13075/ijomeh.1896.01048 ↩
-
Farhad Vahid, Victoria Stopa, Laurent Malisoux, et al. Established and Emerging Biomarkers to Characterize Persons at Risk for Obesity—Paving the Way for Targeted Clinical Intervention Trials—A Comprehensive Position Paper. Obesity Reviews, 2026. https://doi.org/10.1111/obr.70175 ↩ ↩2
-
Anne Wang, Hertzel C Gerstein, Shun Fu Lee, et al. Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial. Diabetes and Vascular Disease Research, 2021. https://doi.org/10.1177/14791641211002475 ↩ ↩2
-
Sidika E. Karakas. New biomarkers for diagnosis and management of polycystic ovary syndrome. Clinica Chimica Acta, 2017. https://doi.org/10.1016/j.cca.2017.06.009 ↩
-
A. D. Coviello, W. V. Zhuang, K. L. Lunetta, et al. Circulating Testosterone and SHBG Concentrations Are Heritable in Women: The Framingham Heart Study. The Journal of Clinical Endocrinology & Metabolism, 2011. https://doi.org/10.1210/jc.2011-0050 ↩
-
Marcello Maggio, Gian Paolo Ceda, Fulvio Lauretani, et al. SHBG, Sex Hormones, and Inflammatory Markers in Older Women. The Journal of Clinical Endocrinology & Metabolism, 2011. https://doi.org/10.1210/jc.2010-1902 ↩
Pothos builds longitudinal molecular profiles of individuals: whole-genome sequencing, single-cell RNA sequencing, and plasma proteomics, delivered as a detailed report, every data file, and stored cells. Build your profile.